Search

Your search keyword '"Albert, CM"' showing total 412 results

Search Constraints

Start Over You searched for: Author "Albert, CM" Remove constraint Author: "Albert, CM"
412 results on '"Albert, CM"'

Search Results

1. Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update

2. Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort

3. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort

6. Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update.

7. Description and cross-sectional analyses of 25,880 adults and children in the UK National Registry of Rare Kidney Diseases cohort

8. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort

9. Rare disease gene association discovery from burden analysis of the 100,000 Genomes Project data

11. Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis

12. Rare disease gene association discovery from burden analysis of the 100,000 Genomes Project data

13. Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial

14. Harmonization of the Definition of Sudden Cardiac Death in Longitudinal Cohorts of the ESCAPE-NET Consortium

16. List of Contributors

17. 2020 APHRS/HRS Expert Consensus Statement on the Investigation of Decedents with Sudden Unexplained Death and Patients with Sudden Cardiac Arrest, and of Their Families

20. LIST OF CONTRIBUTORS

22. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer

23. Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy

28. Sudden vigorous exercise associated with increased risk of death

29. Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes

30. Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium

31. Gene-gene Interaction Analyses for Atrial Fibrillation

32. Association of Lipid-Related Genetic Variants with the Incidence of Atrial Fibrillation: The AFGen Consortium

33. Female sex as an independent risk factor for stroke in atrial fibrillation: Possible mechanisms

34. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders

35. Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140

38. Identification of a Sudden Cardiac Death Susceptibility Locus at 2q24.2 through Genome-Wide Association in European Ancestry Individuals

41. Blood levels of long-chain n-3 fatty acids and the risk of sudden death

44. A common variant in the β2-adrenergic receptor and risk of sudden cardiac death.

47. Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial.

48. Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial.

Catalog

Books, media, physical & digital resources